| Unique ID issued by UMIN | UMIN000020329 |
|---|---|
| Receipt number | R000023477 |
| Scientific Title | Remission induction with rituximab in Japanese patients with ANCA-associated vascutlitis |
| Date of disclosure of the study information | 2016/01/25 |
| Last modified on | 2017/06/20 18:04:57 |
Remission induction with rituximab in Japanese patients with ANCA-associated vascutlitis
RemIRIT
Remission induction with rituximab in Japanese patients with ANCA-associated vascutlitis
RemIRIT
| Japan |
ANCA-associated vasculitis
| Medicine in general | Pneumology | Nephrology |
| Neurology | Clinical immunology | Ophthalmology |
| Dermatology | Oto-rhino-laryngology |
Others
NO
To investigate the effectiveness of AAV patients treated with rituximab
Safety
remission rate
Observational
| 20 | years-old | <= |
| Not applicable |
Male and Female
MPA and GPA patient treated with rituximab
patient lower than 20 years-old
50
| 1st name | |
| Middle name | |
| Last name | Yoshihiro Arimura |
Kyorin university
Dept. of Nephrology and Rheumatology
6-20-2, Shinkawa, Mitaka-city
0422-47-5511
amed-vas@ks.kyorin-u.ac.jp
| 1st name | |
| Middle name | |
| Last name | Kenji Nagasaka |
Tokyo Medical and Dental University
Dept. of Pharmacovigilance
1-5-45, Yushima, Bunkyo-ku, Tokyo
03-5803-4677
nagasaka.phv@tmd.ac.jp
The strategic study group to establish evidences for the treatment guidelines of intractable vasculitis
Japan Agency for Medical Research and Development
Other
NO
| 2016 | Year | 01 | Month | 25 | Day |
Unpublished
Enrolling by invitation
| 2015 | Year | 06 | Month | 18 | Day |
| 2016 | Year | 01 | Month | 10 | Day |
Cohort study
| 2015 | Year | 12 | Month | 24 | Day |
| 2017 | Year | 06 | Month | 20 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000023477